Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
NCT Number: NCT04607291
This phase I study investigates how well a health service program called Witness CARES Services works in increasing access and adherence to colorectal cancer screening in patients who have not undergone a colorectal screening in the past year. Providing patients with navigational and screening services via Witness CARES Services may improve access to and adherence levels of colorectal screening.
Looking for future studies?
Notify Me50 year–75 year
All sexes
Interventional
Phase 1
Buffalo, New York, 14263, United States
PRIMARY OBJECTIVES:
I. Test the feasibility of Witness CARES (WC) Services to achieve colorectal carcinoma (CRC) screening for non-adherent Medicaid clients.
II. Develop an algorithm for predicting CRC screening outcomes following intervention services.
OUTLINE:
Patients who are not prepared for a colonoscopy or stool test receive educational materials, messages, and videos electronically or by mail with information about colorectal screening and are followed up by phone within 2 weeks. Patients desiring colonoscopy receive navigator assistance with obtaining the screening (e.g.,determining gastrointestinal doctor, scheduling appointment, prep materials and process, transportation, escort). Patients desiring a stool test receive navigator assistance by facilitating fecal tests.
After completion of study, patients are followed up periodically.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Receive Witness CARES services
Ancillary studies
Time frame: Up to 12 months
After CRC screening, satisfaction surveys will be conducted in order to assess the services of the Witness Cares Program.
Below are responses to basic follow-up questions.
Time frame: Up to 12 months
A telephone assessment of 118 self reported questions will be conducted in order to assess what factors are associated with CRC screening.
The outcome of interest is CRC screening (colonoscopy or fecal immunochemical testing (FIT) test), which is treated as a binary outcome.
The potential predictors include basic demographic characteristics as well as the survey sub-scales (based on the 118 self-reported questions).
Time frame: Up to 12 months
Data collected from surveys from the intent to screen clients will be used to help predict CRC screening test most acceptable
Roswell Park Cancer Institute
Other
Increasing Access and Developing Predictors for Colorectal Cancer Screening for Minority and Medicaid Clients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02009449
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT03086096
Colonic Diseases, Colorectal Carcinoma
Vienna, State of Vienna, Austria
View Trial DetailsNCT04868773
CRC, Colonic Diseases
Orange, California, United States
View Trial DetailsNCT04081779
Breast Carcinoma, Breast Diseases
Seattle, Washington, United States
View Trial Details